| 股號 / 名稱 | 營業現金流 | 自由現金流 | 淨現金流 |
| ROIV Roivant Sciences Ltd | -210,452,000.0 | -210,807,000.0 | 5,262,270,000.0 |
| BMY 施貴寶 | 4,252,000,000.0 | 3,922,000,000.0 | 3,951,000,000.0 |
| AZN AstraZeneca PLC | 2,380,000,000.0 | 1,434,000,000.0 | 1,018,000,000.0 |
| ARGX argenx SE | -134,891,000.0 | -178,224,000.0 | 938,275,000.0 |
| GH Guardant Health Inc | -78,728,000.0 | -82,805,000.0 | 676,324,000.0 |
| REGN 雷傑納榮製藥 | 1,089,700,000.0 | 776,200,000.0 | 577,600,000.0 |
| IMVT Immunovant Inc | -47,098,000.0 | -47,229,000.0 | 421,009,000.0 |
| GILD 吉利德科學 | 2,169,000,000.0 | 1,954,000,000.0 | 380,000,000.0 |
| LEGN Legend Biotech Corp | -95,645,000.0 | -102,494,000.0 | 314,243,000.0 |
| ACLX Arcellx Inc | 58,248,000.0 | 52,955,000.0 | 267,856,000.0 |
| BEAM Beam Therapeutics Inc | 135,073,000.0 | 131,484,000.0 | 266,885,000.0 |
| NUVL Nuvalent Inc | -30,209,000.0 | 246,953,000.0 | |
| SNDX Syndax Pharmaceuticals Inc | -41,349,000.0 | 200,844,000.0 | |
| ARVN Arvinas Inc | -83,100,000.0 | -83,200,000.0 | 198,000,000.0 |
| PHAT Phathom Pharmaceuticals Inc | -43,797,000.0 | -44,272,000.0 | 167,721,000.0 |
| MNKD MannKind Corp | 21,678,000.0 | 15,804,000.0 | 155,464,000.0 |
| EYPT EyePoint Pharmaceuticals Inc | -23,109,000.0 | -23,992,000.0 | 148,228,000.0 |
| RARE Ultragenyx Pharmaceutical Inc | -83,904,000.0 | -85,504,000.0 | 140,792,000.0 |
| BHVN Biohaven Ltd | -114,881,000.0 | -115,351,000.0 | 126,130,000.0 |
| XOMA XOMA Corp | -3,927,000.0 | 126,078,000.0 | |
| ILMN Illumina Inc | 224,000,000.0 | 173,000,000.0 | 121,000,000.0 |
| RGEN Repligen Corp | 29,065,000.0 | 17,948,000.0 | 120,544,000.0 |
| BGNE Beigene Ltd | -221,638,000.0 | -388,549,000.0 | 105,092,000.0 |
| RNA Avidity Biosciences Inc | 16,501,000.0 | 15,638,000.0 | 99,432,000.0 |
| ANNX Annexon Inc | -23,477,000.0 | -23,484,000.0 | 91,951,000.0 |
| ACAD ACADIA Pharmaceuticals Inc | 85,389,000.0 | 85,389,000.0 | 90,464,000.0 |
| VTGN Vistagen Therapeutics Inc | -4,535,400.0 | -4,567,700.0 | 88,950,800.0 |
| QGEN Qiagen NV | 151,368,000.0 | 99,146,000.0 | 88,149,000.0 |
| IBRX Immunitybio Inc | -115,271,000.0 | -123,226,000.0 | 87,490,000.0 |
| STTK Shattuck Labs Inc | -19,419,000.0 | -19,436,000.0 | 84,994,000.0 |
| CABA Cabaletta Bio Inc | -16,448,000.0 | -16,633,000.0 | 77,737,000.0 |
| SWTX SpringWorks Therapeutics Inc | -62,705,000.0 | -60,403,000.0 | 77,161,000.0 |
| GLUE Monte Rosa Therapeutics Inc | 29,634,000.0 | 27,945,000.0 | 69,104,000.0 |
| MGTX MeiraGTx Holdings PLC | -14,547,000.0 | -17,577,000.0 | 66,246,000.0 |
| CCCC C4 Therapeutics Inc | -24,009,000.0 | -24,166,000.0 | 65,608,000.0 |
| ALGS Aligos Therapeutics Inc | -22,658,000.0 | -22,665,000.0 | 65,271,000.0 |
| ETNB 89Bio Inc | -34,293,000.0 | -34,297,000.0 | 64,235,000.0 |
| ZYME Zymeworks Inc | 13,954,000.0 | 12,200,000.0 | 63,225,000.0 |
| HCM HUTCHMED (China) Ltd | -7,145,000.0 | -15,398,000.0 | 60,593,000.0 |
| WVE WAVE Life Sciences Ltd | -33,239,000.0 | -33,595,000.0 | 60,425,000.0 |
| MYGN Myriad Genetics Inc | -54,700,000.0 | -68,200,000.0 | 55,900,000.0 |
| ATXS Astria Therapeutics Inc | -30,238,000.0 | -30,254,000.0 | 55,724,000.0 |
| SABS SAB Biotherapeutics Inc | -13,446,720.0 | -13,514,580.0 | 54,140,580.0 |
| ADAP Adaptimmune Therapeutics PLC | -14,676,000.0 | -15,503,000.0 | 53,945,000.0 |
| EWTX Edgewise Therapeutics Inc | -26,830,000.0 | -26,991,000.0 | 53,140,000.0 |
| XENE Xenon Pharmaceuticals Inc | -35,465,000.0 | -35,543,000.0 | 49,069,000.0 |
| ITCI Intra-Cellular Therapies Inc | -2,061,000.0 | -2,062,000.0 | 48,365,000.0 |
| ITOS Iteos Therapeutics Inc | -13,765,000.0 | -15,177,000.0 | 47,050,000.0 |
| KROS Keros Therapeutics Inc | -25,459,000.0 | -26,000,000.0 | 43,254,000.0 |
| TERN Terns Pharmaceuticals Inc | -19,316,000.0 | -19,360,000.0 | 42,033,000.0 |
| EDIT Editas Medicine Inc | -22,240,000.0 | -23,547,000.0 | 41,114,000.0 |
| GERN Geron Corp | -40,938,000.0 | -41,002,000.0 | 39,893,000.0 |
| NEO Neogenomics Inc | 17,784,000.0 | 10,727,000.0 | 36,249,000.0 |
| GRTS Gritstone bio Inc | -19,508,000.0 | -19,699,000.0 | 34,504,000.0 |
| SRRK Scholar Rock Holding Corp | -37,349,000.0 | -37,349,000.0 | 34,052,000.0 |
| CGEM Cullinan Therapeutics Inc | -18,131,000.0 | -18,131,000.0 | 33,587,000.0 |
| KYMR Kymera Therapeutics Inc | 8,045,000.0 | -3,580,000.0 | 28,931,000.0 |
| ANIP ANI Pharmaceuticals Inc | 44,740,000.0 | 42,461,000.0 | 28,043,000.0 |
| SYRS Syros Pharmaceuticals Inc | -18,562,000.0 | -18,600,000.0 | 26,340,000.0 |
| SLDB Solid Biosciences Inc | -20,823,000.0 | -20,913,000.0 | 24,978,000.0 |
| EBS Emergent BioSolutions Inc | 32,100,000.0 | 20,700,000.0 | 23,900,000.0 |
| OPT Opthea Ltd | 51,248,220.0 | 51,265,910.0 | 23,322,780.0 |
| CHRS Coherus BioSciences Inc | -12,937,000.0 | -12,971,000.0 | 22,632,000.0 |
| REPL Replimune Group Inc | -47,123,000.0 | -48,842,000.0 | 21,676,000.0 |
| PSTX Poseida Therapeutics Inc | -28,744,000.0 | -29,053,000.0 | 18,969,000.0 |
| NUVB Nuvation Bio Inc | -15,029,000.0 | -15,042,000.0 | 18,254,000.0 |
| VERA Vera Therapeutics Inc | -25,144,000.0 | -25,207,000.0 | 18,240,000.0 |
| BPMC Blueprint Medicines Corp | -78,928,000.0 | -83,601,000.0 | 15,856,000.0 |
| TRDA Entrada Therapeutics Inc | -4,013,000.0 | -4,989,000.0 | 15,720,000.0 |
| EXAS Exact Sciences Corp | 69,549,000.0 | 34,127,000.0 | 14,766,000.0 |
| VRNA Verona Pharma PLC | -10,402,000.0 | -10,402,000.0 | 14,406,000.0 |
| CLDX Celldex Therapeutics Inc | -32,533,000.0 | -33,199,000.0 | 13,680,000.0 |
| CMRX Chimerix Inc | -14,588,000.0 | -14,588,000.0 | 13,543,000.0 |
| CYTK Cytokinetics Inc | -74,037,000.0 | -74,114,000.0 | 13,332,000.0 |
| FEMY Femasys Inc | -3,035,980.0 | -3,080,880.0 | 13,023,640.0 |
| LIFE aTyr Pharma Inc | -11,062,000.0 | -11,079,000.0 | 12,790,000.0 |
| UBX UNITY Biotechnology Inc | -7,575,000.0 | -7,575,000.0 | 11,927,000.0 |
| QURE Uniqure NV | -49,541,000.0 | -51,579,000.0 | 11,908,000.0 |
| SCPH scPharmaceuticals Inc | -15,158,000.0 | -15,195,000.0 | 11,772,000.0 |
| MGNX MacroGenics Inc | -28,037,000.0 | -28,657,000.0 | 11,058,000.0 |
| ABEO Abeona Therapeutics Inc | -9,235,000.0 | -9,272,000.0 | 9,761,000.0 |
| ANAB AnaptysBio Inc | -34,349,000.0 | -34,629,000.0 | 9,670,000.0 |
| EFTR eFFECTOR Therapeutics Inc | -5,566,000.0 | -5,620,000.0 | 9,489,000.0 |
| HOOK HOOKIPA Pharma Inc | -11,224,000.0 | -11,646,000.0 | 9,426,000.0 |
| KZR Kezar Life Sciences Inc | -18,980,000.0 | -18,981,000.0 | 8,995,000.0 |
| ABUS Arbutus Biopharma Corp | -17,292,000.0 | -17,292,000.0 | 8,754,000.0 |
| FBIO Fortress Biotech Inc | -34,935,000.0 | -39,963,000.0 | 8,620,000.0 |
| KURA Kura Oncology Inc | -34,308,000.0 | -34,324,000.0 | 8,578,000.0 |
| FATE Fate Therapeutics Inc | -36,637,000.0 | -36,818,000.0 | 8,536,000.0 |
| INAB IN8BIO, Inc. | -4,850,000.0 | -4,922,000.0 | 8,430,000.0 |
| OCUP Ocuphire Pharma Inc | 4,548,000.0 | 8,151,000.0 | |
| IMNM Immunome Inc | -17,459,000.0 | -17,808,000.0 | 8,038,000.0 |
| TNGX Tango Therapeutics Inc | -27,467,000.0 | -27,693,000.0 | 7,852,000.0 |
| CSTL Castle Biosciences Inc | 18,587,000.0 | 14,794,000.0 | 7,618,000.0 |
| LQDA Liquidia Corp | -15,982,000.0 | -16,188,000.0 | 7,454,000.0 |
| CYTH Cyclo Therapeutics Inc | -4,294,890.0 | -4,297,310.0 | 7,444,780.0 |
| PLRX Pliant Therapeutics Inc | -25,102,000.0 | -25,163,000.0 | 7,038,000.0 |
| KRON Kronos Bio Inc | -25,024,000.0 | -25,055,000.0 | 6,727,000.0 |
| TRVI Trevi Therapeutics Inc | -6,359,000.0 | -6,381,000.0 | 6,432,000.0 |
| CRDF Cardiff Oncology Inc | -7,139,000.0 | -7,147,000.0 | 6,422,000.0 |
載入數據中...
最新要聞
和生物製藥相關的產業概念股
生物製藥概念股相關指標排名
生物製藥每月營收
生物製藥每股盈餘
生物製藥每股淨值
生物製藥損益表
生物製藥總資產
生物製藥負債和股東權益
生物製藥現金流量表
生物製藥利潤比率
生物製藥營業費用率拆解
生物製藥杜邦分析
生物製藥ROE / ROA
生物製藥經營週轉能力
生物製藥營運週轉天數
生物製藥現金股利發放率
生物製藥財務結構比率
生物製藥流速動比率
生物製藥利息保障倍數
生物製藥現金流量分析
生物製藥營業現金流對淨利比
生物製藥盈餘再投資比率
生物製藥月營收成長率
生物製藥營收成長率
生物製藥毛利成長率
生物製藥營業利益成長率
生物製藥稅後淨利成長率
生物製藥每股盈餘成長率
生物製藥本益比評價
生物製藥股價淨值比評價
生物製藥現金股利殖利率
生物製藥平均現金股息殖利率
生物製藥董監持股比例
生物製藥董監持股質押比例